Variations in DNA subtype and antifungal susceptibility among clinical isolates of Candida tropicalis

Diagnostic Microbiology and Infectious Disease

Volumn 27, Issue 3, 1997, Pages 63-67

  Zhang, J ^a   Hollis, R J ^a   Pfaller, Michael A ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; FLUCONAZOLE; FLUCYTOSINE; FUNGAL DNA; ITRACONAZOLE; RESTRICTION ENDONUCLEASE;

ANTIFUNGAL ACTIVITY; ARTICLE; CANDIDA TROPICALIS; DNA DETERMINATION; DNA STRUCTURE; GENETIC VARIABILITY; HOSPITAL INFECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MINIMUM INHIBITORY CONCENTRATION; PRIORITY JOURNAL; STRAIN DIFFERENCE;

AMPHOTERICIN B; ANTIFUNGAL AGENTS; CANDIDA; CANDIDIASIS; CROSS INFECTION; DNA, FUNGAL; ELECTROPHORESIS, GEL, PULSED-FIELD; FLUCONAZOLE; FLUCYTOSINE; HUMANS; ITRACONAZOLE; MICROBIAL SENSITIVITY TESTS; MYCOLOGICAL TYPING TECHNIQUES; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; TRIAZOLES;

EID: 0030998822     PISSN: 07328893     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0732-8893(97)00002-3     Document Type: Article

References (17)

1. Doebbeling BN, Hollis RJ, Isenberg HD, Wenzel RP, Pfaller MA (1991) Restriction fragment analysis of a Candida tropicalis outbreak of sternal wound infections. J Clin Microbiol 29:1268-1270.
2. Doebelling BN, Lehman PF, Hollis RJ, Wu LC, Widmer AF, Voss A, Pfaller MA (1993) Comparison of pulsed-field gel electrophoresis with isoenzyme profiles as a typing system for Candida tropicalis. Clin Infect Dis 16:377-383.
3. Ferra C, Doebbeling BN, Hollis RJ, Pfaller MA, Lee CK, Gingrich RD (1994) Candida tropicalis vertebral osteomyelitis: A late sequelae of fungemia. Clin Infect Dis 19:697-703.
4. Horn R, Wong B, Kiehn TE, Armstrong D (1985) Fungemia in a cancer hospital: Changing frequency, earlier onset, and results of therapy. Rev Infect Dis 7:646-655.
5. Komshian SV, Uwaydah Ak, Sobel JD, Crane LR (1989) Fungemia caused by Candida species and Torulopsis glabrata in the hospitalized patient: Frequency, characteristics, and evaluation of factors influencing outcome. Rev Infect Dis 11:379-390.
6. National Committee for Clinical Laboratory Standards (NCCLS) (1995) Reference method for broth dilution antifungal susceptibility for yeasts: tentative standard M27-T. Villanova, PA: NCCLS.
7. Pfaller M, Cabezudo I, Koontz F, Bale M, Gingrich R (1987) Predictive value of surveillance cultures for systemic infection due to Candida species. Eur J Clin Microbiol 6:628-633.
8. Pfaller MA, Bale MJ, Buschelman B, Rhomberg P (1994) Antifungal activity of a new triazole, D0870, compared with four other antifungal agents tested against clinical isolates of Candida and Torulopsis glabrata. Diagn Microbiol Infect Dis 19:75-80.
9. Pfaller MA, Bale M, Buschelman B, Lancaster M, Espinel-Ingroff A, Rex JH, Rinaldi MG, Cooper CR, McGinnis MR (1995) Quality control guidelines for National Committee for Clinical Laboratory Standards recommended broth macrodilution testing of amphotericin B, fluconazole, and flucytosine. J Clin Microbiol 33:1104-1107.
10. Pfaller MA (1996) Nosocomial candidiasis: Emerging species, reservoirs, and modes of transmission. Clin Infect Dis 22(suppl 2):589-594.
11. Rex JH, Pfaller MA, Barry AI, Nelson PW, Webb CD (1995) Antifungal susceptibility testing of isolates from a randomized, multicenter trial of fluconazole versus amphotericin B as treatment of non-neutropenic patients with candidemia. Antimicrob Agents Chemother 39:40-44.
12. Rex JH, Pfaller MA, Lancaster M, Odds FC, Bolmstrom A, Rinaldi MG (1996) Quality control guidelines for National Committee for Clinical Laboratory Standards recommended broth macrodilution testing of ketoconazole and itraconazole. J Clin Microbiol 34:816-817.
13. Sandford GR, Merz WG, Wingard JR, Charache P, Saral R (1980) The value of fungal surveillance cultures as predictors of systemic fungal infections. J Infect Dis 142: 503-509.
14. Soll DR, Staebell M, Langtimm CJ, Pfaller M, Hicks J, Rao TVG (1988) Multiple Candida strains in the course of a single systemic infection. J Clin Microbiol 26:1448-1459.
15. Warren NG, Hazen KC (1995) Candida, Cryptococcus, and other yeasts of medical importance. In Manual of Clinical Microbiology, 6th edition, Eds, PR Murray, EJ Baron, MA Pfaller, FC Tenover, RH Yolken. Washington, DC: American Society for Microbiology, pp. 723-737.
16. Wingard JR, Merz WG, Saral R (1979) Candida tropicalis: A major pathogen in immunocompromised patients. Ann Intern Med 91:539-543.
17. Wingard JR (1995) Importance of Candida species other than C. albicans as pathogens in oncology patients. Clin Infect Dis 20:115-125.